Stephanie – Interview 59
Wegener’s granulomatosis is rare among young people and can affect many organs in the body, it can also be life threatening. Stephanie was invited to take part in a trial on improving the treatment of Wegener’s granulomatosis and after discussing it with her mum, she agreed to take part.
Stephanie aged 18, of mixed ethnic origin; Greek-English, is a student, and lives with her parents and sibling at home. At the age of 15 Stephanie was diagnosed with Wegener’s granulomatosis that causes inflammation of the small and medium blood vessels. Wegeners granulomatosis is rare among young people and can affect many organs in the body, it can also be life threatening.
Stephanie was very poorly in hospital when she was invited to take part in the trial. It was quite overwhelming at the time to take in all the information, but after discussing it with her mum she agreed to take part. She says she wanted to take part because the trial offered the chance to take a drug that had fewer side effects than the usual or standard treatment and could be taken at home as a tablet, unlike the usual treatment that involves regularly attending the hospital for treatment. Although she received plenty of information she felt she received lots of the wrong information. Stephanie wanted to know the pure facts; about the side effects she may experience, and did experience, as a result of taking the trial drug.
Stephanie feels that clinical trials in young people are important and says that young people are perfect candidates; because they are more likely to bounce back;. She says taking part may encourage you to take part in future trials, because you have had the experience and understand what it is like. However, she says that it is important that young people asks questions especially if there is something that you don’t understand about a trial or the treatment.